1. Home
  2. Labeler Index
  3. Cspc Ouyi Pharmaceutical Co. Ltd
  4. 24075-0411
  5. NDC Package Code: 24075-0411-3 Conjupri

NDC Package 24075-0411-3 Conjupri

Levamlodipine Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
24075-0411-3
Package Description:
2.5 mg in 1 BOTTLE
Product Code:
24075-0411
Proprietary Name:
Conjupri
Non-Proprietary Name:
Levamlodipine
Substance Name:
Levamlodipine Maleate
Usage Information:
Levamlodipine is contraindicated in patients with known sensitivity to amlodipine.
11-Digit NDC Billing Format:
24075041103
NDC to RxNorm Crosswalk:
  • RxCUI: 2377367 - levamlodipine 2.5 MG Oral Tablet
  • RxCUI: 2377367 - levamlodipine 2.5 MG (equivalent to levamlodipine maleate 3.2 MG) Oral Tablet
  • RxCUI: 2377369 - CONJUPRI 2.5 MG Oral Tablet
  • RxCUI: 2377369 - levamlodipine 2.5 MG Oral Tablet [Conjupri]
  • RxCUI: 2377369 - Conjupri 2.5 MG (equivalent to levamlodipine maleate 3.2 MG) Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Cspc Ouyi Pharmaceutical Co. Ltd
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • LEVAMLODIPINE MALEATE 2.5 mg/2.5mg
    • Sample Package:
    No
    FDA Application Number:
    NDA212895
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    10-08-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    24075-0411-52.5 mg in 1 BOTTLE
    24075-0411-92.5 mg in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 24075-0411-3?

    The NDC Packaged Code 24075-0411-3 is assigned to a package of 2.5 mg in 1 bottle of Conjupri, a human prescription drug labeled by Cspc Ouyi Pharmaceutical Co. Ltd. The product's dosage form is tablet and is administered via oral form.

    Is NDC 24075-0411 included in the NDC Directory?

    Yes, Conjupri with product code 24075-0411 is active and included in the NDC Directory. The product was first marketed by Cspc Ouyi Pharmaceutical Co. Ltd on October 08, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 24075-0411-3?

    The 11-digit format is 24075041103. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-124075-0411-35-4-224075-0411-03